Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-830-3 | CAS number: 7758-02-3
Endpoint summary
Administrative data
Description of key information
Case studies are presented for humans exposed to bromide containing substances (usually prescribed or over-the-counter medications). These case studies detail the effects of excessive bromide intake with symptoms of neurotoxicity being the most prevalent. The observed effects were reversible in almost all cases following removal of the source of bromide intake.
Additional information
Bromide salts are known central nervous system depressants and bromide-containing medications have been in use for 150 years for the treatment of epilepsy and as effective anticonvulsants. Bromide containing medications are still available today as prescription drugs, and as some over-the-counter medications such as bromopheniramine and dextromethorphan bromide. Case studies of bromide intoxication, also known as bromism, have been described in a number of medical and scientific publications in recent years.
Case studies are presented for humans exposed to bromide containing substances (usually prescribed or over-the-counter medications). These case studies detail the effects of excessive bromide intake with symptoms of neurotoxicity being the most prevalent. The observed effects were reversible in almost all cases following removal of the source of bromide intake.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
